The consequences of hypoglycaemia.
Amiel SA.
Diabetologia. 2021 May;64(5):963-970. doi: 10.1007/s00125-020-05366-3. Epub 2021 Feb 7.
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.
International Hypoglycaemia Study Group.
Lancet Diabetes Endocrinol. 2019 May;7(5):385-396. doi: 10.1016/S2213-8587(18)30315-2. Epub 2019 Mar 27.
Hypoglycaemia.
Muneer M.
Adv Exp Med Biol. 2021;1307:43-69. doi: 10.1007/5584_2020_534.
Exercise-induced hypoglycaemia in type 1 diabetes.
Cockcroft EJ, Narendran P, Andrews RC.
Exp Physiol. 2020 Apr;105(4):590-599. doi: 10.1113/EP088219. Epub 2020 Jan 9.
Drug-induced hypoglycaemia: an update.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K.
Drug Saf. 2011 Jan 1;34(1):21-45. doi: 10.2165/11538290-000000000-00000.
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.
Philis-Tsimikas A, Asong M, Franek E, Jia T, Rosenstock J, Stachlewska K, Watada H, Kellerer M.
Lancet Diabetes Endocrinol. 2023 Jun;11(6):414-425. doi: 10.1016/S2213-8587(23)00093-1. Epub 2023 May 3.
Reducing inpatient hypoglycaemia.
Holt RIG.
Diabet Med. 2020 Jul;37(7):1085-1086. doi: 10.1111/dme.14334.
[Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].
Scheen AJ.
Rev Med Liege. 2014 Feb;69(2):110-5.
Intranasal Glucagon.
Kalra S, Dhingra M.
J Pak Med Assoc. 2019 Aug;69(8):1219-1221.
Modern insulin treatment for type 2 diabetes.
Grønlund E, Lund L, Vilsbøll T, Hædersdal S.
Ugeskr Laeger. 2024 Jul 8;186(28):V03240172. doi: 10.61409/V03240172.
